Initial results of Sana Biotechnology’s new gene-editing technique demonstrate that transplanted islet cells successfully produced insulin in a man with type 1 diabetes – without the need for ...
Abbott has announced that its latest continuous glucose monitor, the FreeStyle Libre 3, is now covered under Medicare. Following news in April that the FDA cleared a separate handheld reader for ...
The American Diabetes Association recently released major diabetes care updates, which include new recommendations on diabetes technology, therapy, and preventative health. The ADA's annual Standards ...
Food noise became a popular topic of conversation when people taking newer diabetes and weight loss drugs noticed that the medication quieted their thoughts about food. Researchers are still learning ...
Consuming foods that are high in protein and fiber tends to impact blood sugar less than those made with simple or refined carbohydrates and added sugar. Foods that don’t spike blood sugar as much ...
Wegovy, a once-weekly injectable medication (semaglutide), is approved to treat obesity and excess weight – conditions that can lead to type 2 diabetes and prediabetes. In 2021, the FDA approved Novo ...
What do these numbers mean, what’s the target, and how can they provide insight into better diabetes management? Example days included! Glucose monitoring is one of the most important tools in ...
Stelo by Dexcom, an over-the-counter biosensor and continuous glucose monitor (CGM) designed for people with prediabetes or people with type 2 diabetes who do not take insulin, is now available in the ...
The t:slim X2 insulin pump is a small, tubed pump with a color touchscreen. Users can control the pump directly from the device or using an iPhone or Android smartphone app. The t:slim X2 is part of ...
Stress affects your blood sugar more than you might think – certain hormones released during stress can cause blood sugar to spike and make diabetes harder to manage. Recognizing signs of stress, like ...
Why is this study important? GLP-1 medications have traditionally been off-limits for people with type 1 diabetes due to concerns around risks like hypoglycemia and diabetic ketoacidosis (DKA). That ...
As people with diabetes age, the glucose management strategies they’ve relied on for decades may need some adjustment. Researchers at ATTD 2025 presented various strategies for simplifying treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results